Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2020. Start Trial.
Date Value
October 06, 2026 2.796
October 05, 2026 3.101
October 02, 2026 3.211
October 01, 2026 3.263
September 30, 2026 3.254
September 29, 2026 3.12
September 28, 2026 3.068
September 25, 2026 2.896
September 24, 2026 3.010
September 23, 2026 3.034
September 22, 2026 3.101
September 21, 2026 2.915
September 18, 2026 2.867
September 17, 2026 2.791
September 16, 2026 2.805
September 15, 2026 2.848
September 14, 2026 2.958
September 11, 2026 2.958
September 10, 2026 2.934
September 09, 2026 3.020
September 08, 2026 3.101
September 04, 2026 3.239
September 03, 2026 3.320
September 02, 2026 3.296
September 01, 2026 3.278
Date Value
August 31, 2026 3.344
August 28, 2026 3.359
August 27, 2026 3.650
August 26, 2026 3.769
August 25, 2026 3.845
August 24, 2026 3.769
August 21, 2026 3.592
August 20, 2026 3.459
August 19, 2026 3.654
August 18, 2026 3.554
August 17, 2026 3.526
August 14, 2026 3.540
August 13, 2026 3.492
August 12, 2026 3.573
August 11, 2026 3.425
August 10, 2026 3.406
August 07, 2026 3.468
August 06, 2026 3.416
August 05, 2026 3.516
August 04, 2026 3.778
August 03, 2026 3.478
July 31, 2026 3.373
July 30, 2026 3.430
July 29, 2026 3.225
July 28, 2026 3.254

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 2.588
Alnylam Pharmaceuticals, Inc. 22.17
Savara, Inc. 6.999
Vericel Corp. 5.620
Biogen, Inc. 1.742

Price to Book Value Related Metrics

PS Ratio 590.40
Price 5.65
Earnings Yield -9.01%
Market Cap 569.10M